论文部分内容阅读
目的 分析成都市2016年恶性肿瘤发病和死亡情况, 为开展恶性肿瘤干预工作提供依据.方法 按照全国肿瘤中心制定的审核方法和评价标准, 对成都市2016年重点慢性病监测系统和居民死亡原因直报系统中恶性肿瘤发病和死亡资料进行分析.采用国际死因分类法 (ICD-10) 进行死因分类, 采用Excel 2007及SPSS软件进行统计分析.结果 成都市2016年恶性肿瘤 (全部恶性肿瘤和中枢神经系统良性肿瘤) 总报告发病病例36 508例, 总报告发病率为260.97/10万, 其中, 男性为316.52/10万, 女性为205.94/10万.恶性肿瘤总报告死亡病例26 267例, 总报告死亡率为187.77/10万, 其中, 男性为248.09/10万, 女性为127.97/10万.成都市2016年恶性肿瘤报告发病率居前5位的依次是肺癌、肠癌、肝癌、食管癌和胃癌, 占所有恶性肿瘤发病的60.17％.恶性肿瘤死因的前5位依次是肺癌、肠癌、肝癌、食管癌和胃癌, 占所有恶性肿瘤死亡的79.18％.结论 肺癌是成都市2016年居民报告发病率和死亡率最高的恶性肿瘤, 应引起高度重视.男性恶性肿瘤报告发病率和死亡率均高于女性, 建议针对男性恶性肿瘤的危险因素开展干预.“,”Objective To analyze the incidence and mortality of malignant tumor registration in Chengdu in 2016, provide evidence for cancer prevention and control.Methods On basis of the method and criteria of data quality from the National Central Cancer Registry (NCCR), the data of 2016 from Chengdu direct reporting system of chronic disease and mortality surveillance network were checked and evaluated.The new cases and all cases died of cancer in 2016 in Chengdu were classified according to ICD-10.The data were analyzed by using of Excel 2007 and SPSS software.Results In 2016, the number of new cancer cases (including all malignant tumors and benign tumors of the central nervous system) was 36 508.The incidence rate was 260.97/100 000 in all, which 316.52/100 000 in male and 205.94/100 000 in female.A total of 26 267 deaths from malignant tumors were reported, the mortality rate was 187.77/100 000, which 248.09/100 000 in male and 127.97/100 000 in female.In 2016, the top five malignant tumors reported in Chengdu were lung cancer, intestinal cancer, liver cancer, esophageal cancer and gastric cancer, accounted for 60.17％ in all malignant tumors.The main causes of death of malignant tumors were lung cancer, intestinal cancer, liver cancer, esophageal cancer and gastric cancer.The top five malignant tumors accounted for 79.18％ of all malignant tumors.Conclusion The incidence and mortality rate of lung cancer are top in Chengdu, that effective measures should be taken for its prevention.The cancer incidence and mortality rate are both higher in male than those in female.It is suggested that intervention should be carried out for the risk factors in males.